Free Trial

Envista (NVST) Competitors

Envista logo
$19.83 +0.64 (+3.32%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NVST vs. SOLV, SNN, PEN, GKOS, STVN, BLCO, INSP, NARI, PRCT, and IRTC

Should you be buying Envista stock or one of its competitors? The main competitors of Envista include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry.

Envista vs.

Envista (NYSE:NVST) and Solventum (NYSE:SOLV) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, community ranking, dividends and risk.

Envista received 33 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 37.78% of users gave Envista an outperform vote while only 5.56% of users gave Solventum an outperform vote.

CompanyUnderperformOutperform
EnvistaOutperform Votes
34
37.78%
Underperform Votes
56
62.22%
SolventumOutperform Votes
1
5.56%
Underperform Votes
17
94.44%

Solventum has a net margin of 0.00% compared to Envista's net margin of -53.42%. Envista's return on equity of 3.76% beat Solventum's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista-53.42% 3.76% 2.24%
Solventum N/A N/A N/A

Solventum has lower revenue, but higher earnings than Envista.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.57B1.33-$100.20M-$7.77-2.55
SolventumN/AN/AN/AN/AN/A

In the previous week, Solventum had 4 more articles in the media than Envista. MarketBeat recorded 7 mentions for Solventum and 3 mentions for Envista. Solventum's average media sentiment score of 0.87 beat Envista's score of 0.20 indicating that Solventum is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Solventum
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Envista currently has a consensus price target of $20.21, suggesting a potential upside of 1.92%. Solventum has a consensus price target of $68.29, suggesting a potential downside of 7.21%. Given Envista's stronger consensus rating and higher probable upside, analysts clearly believe Envista is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
2 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.07
Solventum
1 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Envista beats Solventum on 8 of the 11 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVST vs. The Competition

MetricEnvistaDental equipment & supplies IndustryMedical SectorNYSE Exchange
Market Cap$3.41B$1.08B$5.21B$19.94B
Dividend YieldN/A1.88%5.13%3.71%
P/E Ratio-2.5538.6089.3441.41
Price / Sales1.330.611,240.0416.25
Price / Cash7.305.0943.7519.84
Price / Book0.810.755.315.76
Net Income-$100.20M-$33.08M$122.54M$993.25M
7 Day Performance4.19%5.70%0.59%3.12%
1 Month Performance6.03%13.82%2.55%4.75%
1 Year Performance-16.34%360.07%25.29%18.83%

Envista Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
3.4717 of 5 stars
$19.83
+3.3%
$20.21
+1.9%
-16.3%$3.41B$2.57B-2.5512,800
SOLV
Solventum
0.5083 of 5 stars
$68.41
+2.0%
$68.29
-0.2%
N/A$11.82B$8.26B0.0022,000
SNN
Smith & Nephew
1.872 of 5 stars
$24.00
+0.2%
N/A-10.1%$10.49B$5.64B12.2418,452
PEN
Penumbra
3.896 of 5 stars
$247.82
-1.1%
$258.00
+4.1%
+5.5%$9.51B$1.16B288.164,200
GKOS
Glaukos
3.7199 of 5 stars
$151.97
-2.9%
$147.75
-2.8%
+71.6%$8.38B$360.35M-50.32780Short Interest ↑
STVN
Stevanato Group
N/A€21.93
-4.4%
N/A-18.8%$6.48B$1.09B46.665,635Gap Down
BLCO
Bausch + Lomb
2.9754 of 5 stars
$17.37
-2.2%
$20.58
+18.5%
+19.0%$6.12B$4.68B-16.5413,300
INSP
Inspire Medical Systems
4.8651 of 5 stars
$175.47
-13.3%
$233.58
+33.1%
-11.4%$5.26B$755.59M163.991,011High Trading Volume
NARI
Inari Medical
1.6924 of 5 stars
$79.32
+0.0%
$68.00
-14.3%
+38.4%$4.64B$574.50M-58.76800
PRCT
PROCEPT BioRobotics
2.9036 of 5 stars
$83.05
-4.4%
$97.86
+17.8%
+66.9%$4.33B$199.84M-42.59430Positive News
Gap Down
IRTC
iRhythm Technologies
1.3312 of 5 stars
$95.46
-2.3%
$108.45
+13.6%
-1.1%$2.99B$560.03M-19.641,790

Related Companies and Tools


This page (NYSE:NVST) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners